Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.98 |
| ▸ | BLM | P54132 | 1/20 | 0.98 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.98 |
| ▸ | TSHR | P16473 | 1/20 | 0.85 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.85 |
| ▸ | MTOR | P42345 | 1/20 | 0.85 |
| ▸ | RAB9A | P51151 | 1/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.85 |
| ▸ | DRD4 | P21917 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29786717 | 1.00 | ADRA1A (1.00) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL8011055 | 0.93 | CYP2D6 (0.88) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL19568202 | 0.93 | CYP2D6 (0.86) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL18211393 | 0.93 | HTR1A (0.86) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL29387395 | 0.92 | CYP2D6 (1.00) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL2640211 | 0.92 | CYP2D6 (1.00) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| Hydrochloric Acid SCHEMBL7041045 | 0.91 | CYP2D6 (0.98) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL898147 | 0.89 | CYP2D6 (0.79) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL13314093 | 0.86 | HTR1A (0.75) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 | |
| SCHEMBL14761343 | 0.84 | HTR1A (0.73) | ADRA1AHTR1ACYP2D6CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025226286-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MULTIF UNCTIONAL IMAGING LLC (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250329024-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS IMAGING OF MULTIPLE POSITRON EMISSION TOMOGRAPHY (PET) TRACERS | MultiFunctional Imaging LLC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| CN-120053688-A | Nanometer medicine for regulating tumor immune microenvironment, preparation method, composition and application thereof | 中山大学 | 2025-05-30 | — | — | CN | claimed |
| CN-114821705-B | Human head posture estimation method based on classification before regression | 南京邮电大学 | 2025-02-18 | — | — | CN | claimed |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2024-09-12 | — | — | US | claimed |
| US-12016935-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2024-06-25 | — | — | US | claimed |
| CN-118101957-A | High-performance rendering sub-pixel image compression method and device | 上海通途半导体科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117763638-A | Electrode loss numerical simulation method for metallized polypropylene film capacitor | 昆明理工大学 | 2024-03-26 | — | — | CN | claimed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| US-11559785-B2 | Method for separation of radioactive sample using monolithic body on microfluidic chip | THE UNIVERSITY OF HULL (GB) | 2023-01-24 | — | — | US | claimed |
| CN-109154671-B | Radioactivity detection | 赫尔大学 | 2022-10-04 | — | — | CN | claimed |
| CN-113162042-B | MPPF capacitor failure assessment method in MMC system based on band energy | 重庆大学 | 2022-09-09 | — | — | CN | claimed |
| US-11369955-B2 | Method and apparatus for the analysis of compounds | THE UNIVERSITY OF HULL (GB) | 2022-06-28 | — | — | US | claimed |
| US-20220146492-A1 | CELL MEMBRANE PERMEABILITY RESTORING THERAPY | SHINE IAN BASIL (US) | 2022-05-12 | — | — | US | claimed |
| CN-114410765-A | Application of miRNA molecular marker in schizophrenia detection | 上海大学 | 2022-04-29 | — | — | CN | claimed |
| CN-114203317-A | Method for loading spent fuel assemblies in pressurized water reactor core | 中国核动力研究设计院 | 2022-03-18 | — | — | CN | claimed |
| EP-3953000-A1 | CELL MEMBRANE PERMEABILITY RESTORING THERAPY | Shine, Ian Basil (US) | 2022-02-16 | — | — | EP | claimed |
| EP-1363890-A2 | MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2003-11-26 | — | — | EP | claimed |
| WO-2002062766-A2 | MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-08-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016935-B2 | Methods for detecting CCR2 receptors | CCR2, CCR1, CCR5 | ADRA1A 598/4885HTR1A 1059/4885CYP2D6 2536/4885 |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | HTR2A, HTR5A, HTR6 | ADRA1A 95/4885HTR1A 4/4885CYP2D6 928/4885 |
| US-20240299598-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR5 | ADRA1A 598/4885HTR1A 1059/4885CYP2D6 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.